Increase Innovation (Shanghai) Health Management Co., Ltd. was established.
Increasepharm (HK) Co., Ltd was established
Completed the construction of Beijing Increasepharm Pharmaceutical Safety and Effectiveness Research Co., Ltd. and Increasepharm (Hengqin) Pharmaceutical Research Institute Co., Ltd.;
Preparing to establish Increasepharm (Zhuhai) Innovative Medicine Manufacturing Co., Ltd.;
Formally changed its name to "Beijing Increasepharm Innovative Medicine Co., Ltd.".
Officially changed to "Beijing Increase Innovative Drug Co., Ltd", the company entered a new era of rapid development;
Increasepharm was selected as a G20 reserve enterprise in Beijing during the "13th Five-Year Plan" period;
Increasepharm completed Series A financing in 2016, led by China Industrial Securities Pien Tze Huang Fund.
Established "Traditional Chinese Medicine Dispensing Granules" and "Aerosol Inhalation Preparation Research Center" at the beginning of the year;
Increasepharm (Tianjin) Institute Co., Ltd. was established;
Establish the development strategy of "one body and two wings", with traditional Chinese medicine as the main body, chemical medicine and clinical companies go hand in hand, with equal emphasis on self-research and service.
Integrate various research sections to establish Beijing Increasepharm Research Institute.
Transfer the pharmaceutical factory to focus on research and development.
The company won the honor of "Beijing Patent Demonstration Organization";
Selected as "the first batch of pilot organizations for the implementation of the national trademark strategy";
Won the honor of "Zhongguancun National Independent Innovation Demonstration Zone New Technology and New Service".
Increasepharm won the honor of "2010 Zhongguancun High-growth Enterprise TOP 100".
Construction of new dosage form technology platform.
Establishment of chemical drug research and development center;
Increasepharm won the title of "China Excellent Brand of Independent Innovation".
Increasepharm was recognized as one of the top 100 most growing high-tech small and medium-sized enterprises among the national high-tech enterprises.
The clinical laboratory center was established.
Increasepharm started to build a pharmaceutical factory.
Beijing Increasepharm Technology Co., Ltd. was established.
Beijing Increase Biomedical Company Limited was established.